331 related articles for article (PubMed ID: 31897111)
1. Significant function and research progress of biomarkers in gastric cancer.
Ye DM; Xu G; Ma W; Li Y; Luo W; Xiao Y; Liu Y; Zhang Z
Oncol Lett; 2020 Jan; 19(1):17-29. PubMed ID: 31897111
[TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice.
Abbas M; Habib M; Naveed M; Karthik K; Dhama K; Shi M; Dingding C
Biomed Pharmacother; 2017 Nov; 95():1082-1090. PubMed ID: 28922727
[TBL] [Abstract][Full Text] [Related]
4. Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy.
Cai H; Li M; Deng R; Wang M; Shi Y
Biomark Res; 2022 Aug; 10(1):67. PubMed ID: 36042469
[TBL] [Abstract][Full Text] [Related]
5. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging therapies in unresectable and recurrent gastric cancer.
Jou E; Rajdev L
World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
[TBL] [Abstract][Full Text] [Related]
7. Translating gastric cancer genomics into targeted therapies.
Ang YL; Yong WP; Tan P
Crit Rev Oncol Hematol; 2016 Apr; 100():141-6. PubMed ID: 26947813
[TBL] [Abstract][Full Text] [Related]
8. Serum proteomics for gastric cancer.
Liu W; Yang Q; Liu B; Zhu Z
Clin Chim Acta; 2014 Apr; 431():179-84. PubMed ID: 24525212
[TBL] [Abstract][Full Text] [Related]
9. Current Molecular Targeted Agents for Advanced Gastric Cancer.
Nie S; Yang G; Lu H
Onco Targets Ther; 2020; 13():4075-4088. PubMed ID: 32494161
[TBL] [Abstract][Full Text] [Related]
10. Predictive biomarkers along gastric cancer pathogenetic pathways.
Panarese I; De Vita F; Ronchi A; Romano M; Alfano R; Di Martino N; Zito Marino F; Ferraraccio F; Franco R
Expert Rev Anticancer Ther; 2017 May; 17(5):417-425. PubMed ID: 28277834
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of protein biomarkers of oesophageal and gastric cancers.
Coghlin C; Murray GI
Proteomics Clin Appl; 2016 Apr; 10(4):532-45. PubMed ID: 26582241
[TBL] [Abstract][Full Text] [Related]
12. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for gastric cancer: dilemmas and prospect.
Zhao Q; Cao L; Guan L; Bie L; Wang S; Xie B; Chen X; Shen X; Cao F
Brief Funct Genomics; 2019 Mar; 18(2):107-112. PubMed ID: 30388190
[TBL] [Abstract][Full Text] [Related]
14. Progress in the treatment of advanced gastric cancer.
Song Z; Wu Y; Yang J; Yang D; Fang X
Tumour Biol; 2017 Jul; 39(7):1010428317714626. PubMed ID: 28671042
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. Current status and future perspectives in gastric cancer management.
Roukos DH
Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
[TBL] [Abstract][Full Text] [Related]
17. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
Beeharry MK; Liu WT; Yan M; Zhu ZG
World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer.
Yuan HL; Wang T; Zhang KH
Onco Targets Ther; 2018; 11():3891-3900. PubMed ID: 30013369
[TBL] [Abstract][Full Text] [Related]
20. Incorporating molecular biomarkers into clinical practice for gastric cancer.
Nakamura S; Kanda M; Kodera Y
Expert Rev Anticancer Ther; 2019 Sep; 19(9):757-771. PubMed ID: 31437076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
